Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
This is a phase 3, randomized, multi-center study to evaluate the efficacy and safety of
albumin interferon alfa 2b (alb-IFN)in combination with ribavirin compared with peginterferon
alfa-2a (PEGASYS or PEG-IFNa2a) in combination with ribavirin in subjects with chronic
hepatitis C, genotype 1 who are IFNa treatment naive.